News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
733,499 Results
Type
Article (42211)
Company Profile (274)
Press Release (690998)
Multimedia
Podcasts (96)
Webinars (20)
Section
Business (205345)
Career Advice (2060)
Deals (35648)
Drug Delivery (130)
Drug Development (81711)
Employer Resources (174)
FDA (16543)
Job Trends (15058)
News (347623)
Policy (32809)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2628)
Accelerated approval (49)
Adcomms (27)
Allergies (171)
Alliances (49731)
ALS (214)
Alzheimer's disease (1821)
Antibody-drug conjugate (ADC) (452)
Approvals (16931)
Artificial intelligence (673)
Autoimmune disease (295)
Automation (56)
Bankruptcy (363)
Best Places to Work (11691)
BIOSECURE Act (20)
Biosimilars (223)
Biotechnology (178)
Bladder cancer (196)
Brain cancer (72)
Breast cancer (755)
Cancer (5848)
Cardiovascular disease (475)
Career advice (1751)
Career pathing (43)
CAR-T (333)
CDC (57)
Celiac Disease (3)
Cell therapy (905)
Cervical cancer (47)
Clinical research (70995)
Collaboration (2080)
Company closure (5)
Compensation (1405)
Complete response letters (81)
COVID-19 (2751)
CRISPR (109)
C-suite (1147)
Cystic fibrosis (152)
Data (7967)
Decentralized trials (3)
Denatured (29)
Depression (169)
Dermatology (87)
Diabetes (588)
Diagnostics (6941)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (324)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (285)
Earnings (92201)
Editorial (67)
Employer branding (22)
Employer resources (153)
Events (119955)
Executive appointments (1087)
FDA (20295)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1745)
Gene editing (235)
Generative AI (56)
Gene therapy (727)
GLP-1 (1063)
Government (4751)
Grass and pollen (6)
Guidances (408)
Healthcare (19058)
HIV (80)
Huntington's disease (56)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (97)
Immunology and inflammation (291)
Immuno-oncology (93)
Indications (196)
Infectious disease (3094)
Inflammatory bowel disease (217)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (293)
Interviews (328)
IPO (16688)
IRA (50)
Job creations (3669)
Job search strategy (1449)
JPM (61)
Kidney cancer (19)
Labor market (102)
Layoffs (567)
Leadership (42)
Legal (7967)
Liver cancer (100)
Longevity (32)
Lung cancer (767)
Lymphoma (429)
Machine learning (60)
Management (59)
Manufacturing (1060)
MASH (190)
Medical device (13968)
Medtech (14095)
Mergers & acquisitions (20213)
Metabolic disorders (1514)
mRNA (209)
Multiple sclerosis (188)
NASH (17)
Neurodegenerative disease (433)
Neuropsychiatric disorders (110)
Neuroscience (3380)
Neurotech (1)
NextGen: Class of 2026 (6557)
Non-profit (4550)
Now hiring (78)
Obesity (711)
Opinion (290)
Ovarian cancer (222)
Pain (262)
Pancreatic cancer (306)
Parkinson's disease (371)
Partnered (33)
Patents (600)
Patient recruitment (676)
Peanut (62)
People (59806)
Pharmaceutical (59)
Pharmacy benefit managers (32)
Phase 1 (22124)
Phase 2 (31280)
Phase 3 (23263)
Pipeline (8864)
Policy (321)
Postmarket research (2573)
Preclinical (9460)
Press Release (64)
Prostate cancer (305)
Psychedelics (54)
Radiopharmaceuticals (324)
Rare diseases (1086)
Real estate (6002)
Recruiting (70)
Regulatory (25468)
Reports (56)
Research institute (2438)
Resumes & cover letters (355)
Rett syndrome (39)
RNA editing (23)
RSV (88)
Schizophrenia (180)
Series A (293)
Series B (216)
Service/supplier (11)
Sickle cell disease (112)
Special edition (28)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3668)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (87)
The Weekly (65)
Vaccines (1097)
Venture capital (110)
Weight loss (456)
Women's health (128)
Worklife (20)
Date
Today (93)
Last 7 days (659)
Last 30 days (3523)
Last 365 days (30233)
2026 (12970)
2025 (30277)
2024 (35307)
2023 (40176)
2022 (51265)
2021 (55815)
2020 (54185)
2019 (46643)
2018 (35126)
2017 (32197)
2016 (31619)
2015 (37691)
2014 (31466)
2013 (26494)
2012 (28684)
2011 (29384)
2010 (27420)
Location
Africa (750)
Alabama (93)
Alaska (7)
Arizona (352)
Arkansas (14)
Asia (39866)
Australia (6552)
California (13371)
Canada (3792)
China (1359)
Colorado (569)
Connecticut (579)
Delaware (411)
Europe (86441)
Florida (2006)
Georgia (429)
Hawaii (3)
Idaho (62)
Illinois (1070)
India (91)
Indiana (603)
Iowa (23)
Japan (540)
Kansas (131)
Kentucky (50)
Louisiana (42)
Maine (76)
Maryland (1598)
Massachusetts (9557)
Michigan (367)
Minnesota (728)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (143)
New Hampshire (84)
New Jersey (3510)
New Mexico (29)
New York (3503)
North Carolina (1694)
North Dakota (9)
Northern California (6707)
Ohio (399)
Oklahoma (23)
Oregon (41)
Pennsylvania (2690)
Puerto Rico (29)
Rhode Island (50)
South America (1116)
South Carolina (86)
South Dakota (2)
Southern California (5275)
Tennessee (215)
Texas (2130)
United States (47194)
Utah (399)
Vermont (1)
Virginia (323)
Washington D.C. (81)
Washington State (1066)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
733,499 Results for "gate neurosciences inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Senti Biosciences to Present on Logic-Gated Cell Therapies in Educational Session at AACR Annual Meeting 2026
April 14, 2026
·
3 min read
Press Releases
Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies
April 2, 2026
·
4 min read
Collaboration
Eli Lilly Commits $856M in Biobucks to Gate Bioscience for New Class of Medicines
The collaboration focuses on ‘molecular gates,’ a class of molecules that the startup company Gate Bioscience says can stop pathogenic proteins from leaving the cell.
July 25, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Synthetic Design Lab Unveils First Advanced Logic-Gated ADC at AACR 2026, Achieving ≥10X Improvement in Targeted Cancer Cell Killing
April 20, 2026
·
5 min read
Press Releases
The University of Colorado Anschutz Gates Institute Achieves First-in-U.S. FDA Clearance for Campus-Built CAR T-Cell Therapy
April 3, 2026
·
4 min read
Press Releases
Promatix Biosciences Highlights the Power of its Logic-Gated Proteomics-Driven Bispecific Discovery Platform to Expand the Tumour-Selective Target Space for Next-Generation ADCs at AACR 2026
April 21, 2026
·
7 min read
Press Releases
Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic
November 14, 2025
·
4 min read
Press Releases
Gate Neurosciences Strengthens Focus on the Synapse as a Therapeutic Target with Acquisition of Boost Neuroscience
February 19, 2025
·
4 min read
Press Releases
SK bioscience In-Licenses RSV Preventive mAb Candidate from Gates Medical Research Institute
February 3, 2026
·
5 min read
Press Releases
PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002, Its Next-Generation MDMA Therapeutic, to Jupiter Neurosciences, Inc. (NASDAQ: JUNS) in a Transaction Valued at Over $100 Million
May 20, 2026
·
7 min read
1 of 73,350
Next
